Business Context and Reporting Period
This Form 8-K Current Report was filed by Standard BioTools Inc. on May 10, 2023, with the earliest event reported on May 15, 2023. The filing addresses Item 5.02 regarding the departure of a Chief Financial Officer and the appointment of a new Chief Financial Officer.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation and severance arrangements.
- New CFO Base Salary: $415,000 annually.
- New CFO Target Bonus: 55% of annual base salary.
- New CFO Equity Inducement: 400,000 stock options and Restricted Stock Units (RSUs) valued at $400,000.
- Outgoing CFO Severance: 75% of annual base salary, 9 months of COBRA health coverage, and accelerated equity vesting.
Material Changes
The primary material change is the leadership transition in the finance function effective May 15, 2023:
- Appointment: Jeffrey G. Black was appointed Chief Financial Officer, effective May 15, 2023.
- Departure: Vikram Jog's tenure as Chief Financial Officer ended on May 14, 2023.
- Transition Role: Mr. Jog will serve as a Special Advisor reporting to the CEO from May 15, 2023, through June 9, 2023.
Outlook, Risks, and Unusual Items
The filing details the terms of employment and severance agreements but does not provide forward-looking guidance, risk factors, or commentary on the company's operational outlook. The equity awards granted to the new CFO are subject to vesting schedules tied to continued employment, with the RSU Award fully vesting in May 2027.
Investor Verification Checklist
- Verify the closing stock price on May 15, 2023, to determine the exercise price of the 400,000 stock options granted to the new CFO.
- Review the full text of the Offer Letter (Exhibit 10.1) and Severance Plan Participation Agreement (Exhibit 10.2) for specific vesting conditions and clawback provisions.
- Confirm the specific amount of the outgoing CFO's annual base salary to calculate the exact cash severance payout (75% of base).
- Monitor the transition period ending June 9, 2023, to ensure a smooth handover of financial operations.